"Clatterbridge Cancer Centre – Liverpool is The Clatterbridge Cancer Centre NHS Foundation Trust's flagship new hospital providing specialist cancer care for people in Cheshire & Merseyside and beyond."

During the past decade, Clatterbridge Cancer Centre conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 2 clinical trials were completed. i.e. 13.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clatterbridge Cancer Centre" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 3 trials, followed by "University College, London" with 3 trials sponsored, "University of Birmingham" with 3 trials sponsored, "Akamis Bio" with 2 trials sponsored and "ETOP IBCSG Partners Foundation" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clatterbridge Cancer Centre" #1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Boehringer Ingelheim" with 2 trials as a collaborator and "Celgene" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Clatterbridge Cancer Centre" are "Advanced Breast Cancer" (3 trials), "Ampullary Cancer" (2 trials), "Biliary Tract Cancer" (2 trials), "Breast Cancer" (2 trials) and "Cholangiocarcinoma" (2 trials). Many other conditions were trialed in "Clatterbridge Cancer Centre" in a lesser frequency.

Most popular intervention types in "Clatterbridge Cancer Centre" are "Drug" (26 trials), "Biological" (5 trials), "Other" (3 trials), "Radiation" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (4 trials), "Gemcitabine" (3 trials), "Placebo" (3 trials), "Cisplatin" (2 trials) and "Neratinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clatterbridge Cancer Centre" are 25 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Clatterbridge Cancer Centre". 2 are not yet recruiting, 12 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Clatterbridge Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clatterbridge Cancer Centre, 10 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".